Cynosure Upgrades PicoSure System

Cynosure has upgradied its PicoSure System with the new PicoSure Pro Device. The product is the first and only FDA-cleared 755nm picosecond laser and the PicoSure Pro device delivers energy in a trillionth of a second, utilizing pressure instead of heat to provide safe and effective treatments for unwanted pigmentation and skin revitalization. The Pro device is equipped with two lenses that work to address a variety of concerns across all skin types and the advanced Platinum Focus lens array is used to increase collagen and elastin to help combat wrinkles, acne scars and pores. It is also FDA-cleared for the treatment of pigment in melasma and other hyperpigmentation issues like nevus of Ota and Hori's nevus. Other improvements include a sleek, modern design, intuitive graphic user interface, and new 5MM handpiece that is ideal for treating discrete lesions, lighter Fitzpatrick skin types and smaller treatment areas. "From a 50 percent increase in energy to new handpieces and an adjustable fluence, the performance enhancements made to the PicoSure Pro device provide practitioners with more versatility than ever before, allowing them to efficiently treat more patients per day and provide better outcomes in less time," says Todd Tillemans, CEO of Cynosure. "As inventors of picosecond aesthetic laser technology, we constantly challenge ourselves to continually drive innovation forward. Whether we're developing new devices or improving upon our trusted flagship products, we're focused on addressing the unmet needs of our practitioners to ensure the best possible outcomes for their patients and practice."